The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models
Condition(s) studied
Investigational drug(s) / intervention(s)
Lymph node dissection based on the guidelines: During surgery, mediastinal lymph nodes will be dissected based on the NCCN guidelines (2023) .
Lymph node dissection based on the model: During surgery, lymph nodes will be dissected based on the predicted lymph node status by the model.
Study summary
Investigators combined the clinical and radiomics characteristics of resectable non-small cell lung cancer patients to construct an accurate model for preoperative prediction of mediastinal lymph node status. For the patients in the experimental group, lymph nodes will be dissected based on the predicted lymph node status by the model, while in the control group, the lymph nodes will be dissected according to the NCCN guidelines (2023). Investigators expect that performing lymph node dissection according to the predictive model can lead to better prognosis for patients.
Eligibility
Primary outcome measure(s)
- Consistency rate between preoperative prediction results and postoperative pathological results — 1 week after surgery
Compare postoperative lymph node pathology results with preoperative prediction results
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Zhongnan Hospital of Wuhan University | Wuhan | Hubei |
More Zhongnan Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06768853 on ClinicalTrials.gov ↗ ← All trials in China